Development of Stem Cell-Derived Immune Cells for Off-the-Shelf Cancer Immunotherapies

Cell-based cancer immunotherapy has revolutionized the treatment of hematological malignancies. Specifically, autologous chimeric antigen receptor-engineered T (CAR-T) cell therapies have received approvals for treating leukemias, lymphomas, and multiple myeloma following unprecedented clinical resp...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Yan-Ruide Li, Zachary Spencer Dunn, Yang Zhou, Derek Lee, Lili Yang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	MDPI AG 2021-12-01
Edice:	Cells
Témata:	stem cell engineering allogeneic cancer therapy off-the-shelf cell therapy chimeric antigen receptor (CAR) T cell receptor (TCR) graft-versus-host disease (GvHD)
On-line přístup:	https://www.mdpi.com/2073-4409/10/12/3497
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!